Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 274786, 10 pages
http://dx.doi.org/10.1155/2014/274786
Research Article

Effect of Uncaria tomentosa Extract on Apoptosis Triggered by Oxaliplatin Exposure on HT29 Cells

1University Hospital of Santa Maria, Federal University of Santa Maria (UFSM), Avenida Roraima, Prédio 20, 97105-900 Santa Maria, RS, Brazil
2Postgraduate Program in Pharmaceutical Sciences, UFSM, 97105-900 Santa Maria, RS, Brazil
3Laboratory of Biotechnology and Animal Reproduction, UFSM, 97105-900 Santa Maria, RS, Brazil
4Postgraduate Program in Biochemistry and Toxicology, UFSM, 97105-900 Santa Maria, RS, Brazil
5Postgraduate Program in Agronomy, UFSM, 97105-900 Santa Maria, RS, Brazil
6Lutheran University of Brazil (ULBRA), BR 287, Km 252, 97020-001 Santa Maria, RS, Brazil
7Herbarium Laboratório Botânico Ltda., Avenida Santos Dumont 1100, 83403-500 Colombo, PR, Brazil

Received 17 June 2014; Accepted 17 October 2014; Published 11 November 2014

Academic Editor: Vincenzo De Feo

Copyright © 2014 Liliane Z. de Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. I. Block, A. C. Koch, M. N. Mead, P. K. Tothy, R. A. Newman, and C. Gyllenhaal, “Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials,” International Journal of Cancer, vol. 123, no. 6, pp. 1227–1239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. T. Schumacker, “Reactive oxygen species in cancer cells: live by the sword, die by the sword,” Cancer Cell, vol. 10, no. 3, pp. 175–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. L. Janssen, C. B. Bosman, C. F. M. Sier et al., “Superoxide dismutases in relation to the overall survival of colorectal cancer patients,” British Journal of Cancer, vol. 78, no. 8, pp. 1051–1057, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Hussain, P. Amstad, P. He et al., “p53-Induced up-regulation of MnSOD and GPx but not Catalase increases oxidative stress and apoptosis,” Cancer Research, vol. 64, no. 7, pp. 2350–2356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Priego, F. Feddi, P. Ferrer et al., “Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism,” Molecular Cancer Therapeutics, vol. 7, no. 10, pp. 3330–3342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Heitzman, C. C. Neto, E. Winiarz, A. J. Vaisberg, and G. B. Hammond, “Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae),” Phytochemistry, vol. 66, no. 1, pp. 5–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Keplinger, G. Laus, M. Wurm, M. P. Dierich, and H. Teppner, “Uncaria tomentosa (Willd.) DC.—ethnomedicinal use and new pharmacological, toxicological and botanical results,” Journal of Ethnopharmacology, vol. 64, no. 1, pp. 23–34, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. United States Pharmacopeial Convention, United States Pharmacopeia (USP 36), United States Pharmacopeial Convention, Rockville, Md, USA, 36th edition, 2013.
  9. R. Pilarski, H. Zieliński, D. Ciesiołka, and K. Gulewicz, “Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 18–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Farias, M. do Carmo Araújo, E. S. Zimmermann et al., “Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 856–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Eberlin, L. M. B. dos Santos, and M. L. S. Queiroz, “Uncaria tomentosa extract increases the number of myeloid progenitor cells in the bone marrow of mice infected with Listeria monocytogenes,” International Immunopharmacology, vol. 5, no. 7-8, pp. 1235–1246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Pilarski, B. Filip, J. Wietrzyk, M. Kuraś, and K. Gulewicz, “Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition,” Phytomedicine, vol. 17, no. 14, pp. 1133–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A.-C. Cheng, C.-B. Jian, Y.-T. Huang, C.-S. Lai, P.-C. Hsu, and M.-H. Pan, “Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells,” Food and Chemical Toxicology, vol. 45, no. 11, pp. 2206–2218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. de Martino, J. L. S. Martinot, S. Franceschelli, A. Leone, C. Pizza, and V. de Feo, “Proapoptotic effect of Uncaria tomentosa extracts,” Journal of Ethnopharmacology, vol. 107, no. 1, pp. 91–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Bacher, M. Tiefenthaler, S. Sturm et al., “Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells,” British Journal of Haematology, vol. 132, no. 5, pp. 615–622, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Dreifuss, A. L. Bastos-Pereira, I. A. Fabossi et al., “Uncaria tomentosa exerts extensive anti-neoplastic effects against the walker-256 tumour by modulating oxidative stress and not by alkaloid activity,” PLoS ONE, vol. 8, no. 2, Article ID e54618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Bertol, L. Franco, and B. H. de Oliveira, “HPLC analysis of oxindole alkaloids in Uncaria tomentosa: sample preparation and analysis optimisation by factorial design,” Phytochemical Analysis, vol. 23, no. 2, pp. 143–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–191, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. R. R. Tice, D. Agurell, D. Anderson et al., “Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing,” Environmental and Molecular Mutagenesis, vol. 35, no. 3, pp. 206–221, 2000. View at Google Scholar
  20. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  21. D. P. Nelson and L. A. Kiesow, “Enthalpy of decomposition of hydrogen peroxide by catalase at 25° C (with molar extinction coefficients of H2O2 solutions in the UV),” Analytical Biochemistry, vol. 49, no. 2, pp. 474–478, 1972. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. McCord and I. Fridovich, “Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein),” The Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049–6055, 1969. View at Google Scholar · View at Scopus
  23. S. F. Ali, C. P. Le Bel, and S. C. Bondy, “Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity,” Neurotoxicology, vol. 13, no. 3, pp. 637–648, 1992. View at Google Scholar · View at Scopus
  24. M. Wurm, L. Kacani, G. Laus, K. Keplinger, and M. P. Dierich, “Pentacyclic oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to release a lymphocyte-proliferation-regulating factor,” Planta Medica, vol. 64, no. 8, pp. 701–704, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. G. E. Deng, M. Frenkel, L. Cohen et al., “Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals,” Journal of the Society for Integrative Oncology, vol. 7, no. 3, pp. 85–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. C. Foster, S. Vandenhoek, J. Hana et al., “In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products,” Phytomedicine, vol. 10, no. 4, pp. 334–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. FDA, 2006, http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm.
  28. F. Lentz, A. Tran, E. Rey, G. Pons, and J.-M. Tréluyer, “Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications,” American Journal of PharmacoGenomics, vol. 5, no. 1, pp. 21–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. C. Santos Araújo, I. L. Farias, J. Gutierres et al., “Uncaria tomentosa—adjuvant treatment for breast cancer: clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 676984, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. F. J. Reyes-Zurita, G. Pachón-Peña, D. Lizárraga, E. E. Rufino-Palomares, M. Cascante, and J. A. Lupiáñez, “The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism,” BMC Cancer, vol. 11, article 154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kurokawa and S. Kornbluth, “Caspases and kinases in a death grip,” Cell, vol. 138, no. 5, pp. 838–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Berindan-Neagoe, C. Braicu, V. Pileczki et al., “5-fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells,” Journal of Gastrointestinal and Liver Diseases, vol. 22, no. 1, pp. 37–43, 2013. View at Google Scholar · View at Scopus
  33. X. Yang, H. Y. Chang, and D. Baltimore, “Autoproteolytic activation of pro-caspases by oligomerization,” Molecular Cell, vol. 1, no. 2, pp. 319–325, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Y. Lee, T. Debnath, S.-K. Kim, and B. O. Lim, “Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29,” Food and Chemical Toxicology, vol. 60, pp. 439–447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. U. von Reyher, J. Sträter, W. Kittstein, M. Gschwendt, P. H. Krammer, and P. Möller, “Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis,” Cancer Research, vol. 58, no. 3, pp. 526–534, 1998. View at Google Scholar · View at Scopus
  36. J. O'Connell, M. W. Bennett, K. Nally, A. Houston, G. C. O'Sullivan, and F. Shanahan, “Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict,” Annals of the New York Academy of Sciences, vol. 910, pp. 178–195, 2000. View at Google Scholar · View at Scopus
  37. A. Gonçalves, D. Braguer, G. Carles, N. André, C. Prevôt, and C. Briand, “Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4),” Biochemical Pharmacology, vol. 60, no. 11, pp. 1579–1584, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Lacour, A. Hammann, S. Grazide et al., “Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells,” Cancer Research, vol. 64, no. 10, pp. 3593–3598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Laurent, C. Nicco, C. Chéreau et al., “Controlling tumor growth by modulating endogenous production of reactive oxygen species,” Cancer Research, vol. 65, no. 3, pp. 948–956, 2005. View at Google Scholar · View at Scopus
  40. J. Alexandre, Y. Hu, W. Lu, H. Pelicano, and P. Huang, “Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species,” Cancer Research, vol. 67, no. 8, pp. 3512–3517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Priego, F. Feddi, P. Ferrer et al., “Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism,” Molecular Cancer Therapeutics, vol. 7, no. 10, pp. 3330–3342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Karlsson, T. Kurz, U. T. Brunk, S. E. Nilsson, and C. I. Frennesson, “What does the commonly used DCF test for oxidative stress really show?” Biochemical Journal, vol. 428, no. 2, pp. 183–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Lentz, A. Tran, E. Rey, G. Pons, and J.-M. Tréluyer, “Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications,” American Journal of PharmacoGenomics, vol. 5, no. 1, pp. 21–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Arnould, I. Hennebelle, P. Canal, R. Bugat, and S. Guichard, “Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines,” European Journal of Cancer, vol. 39, no. 1, pp. 112–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. R. N. Seetharam, A. Sood, A. Basu-Mallick, L. H. Augenlicht, J. M. Mariadason, and S. Goel, “Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells,” Anticancer Research, vol. 30, no. 7, pp. 2531–2538, 2010. View at Google Scholar · View at Scopus
  46. A. B. Mallick, R. Seetharam, A. Sood, J. Mariadason, and S. Goel, “Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines,” International Journal of Clinical Oncology, vol. 28, supplement 15, p. 14048, 2010. View at Google Scholar
  47. M.-S. Tsai, S.-H. Weng, Y.-H. Kuo, Y.-F. Chiu, and Y.-W. Lin, “Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1),” Molecular Pharmacology, vol. 80, no. 1, pp. 136–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-C. Ko, Y.-J. Su, S.-T. Lin et al., “Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2,” Lung Cancer, vol. 69, no. 2, pp. 155–164, 2010. View at Publisher · View at Google Scholar · View at Scopus